We are live on ! Find out more
EIGR

Eiger BioPharmaceuticals, Inc.
EIGR

Delisted

EIGR was delisted on the 10th of April, 2024.

Back to rankings

Fund managers haven’t disclosed any holdings of EIGR yet.

EIGR Hedge Fund Activity: Q3 2025 in Review

0 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Eiger BioPharmaceuticals, Inc. (EIGR) for Q3 2025, worth a combined $0 — down 100% from $423K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of EIGR and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was Propel Bio Management, exiting entirely with an estimated $423K sold.

  • 0 institutional investors held Eiger BioPharmaceuticals, Inc. (EIGR) as of Q3 2025, down from 1 in Q2 2025.
  • Funds reported $0 of Eiger BioPharmaceuticals, Inc. stock for Q3 2025, down 100% quarter-over-quarter.
  • 0 funds opened new Eiger BioPharmaceuticals, Inc. positions in Q3 2025 and 1 closed out, a net change of -1 holder.
  • The largest Eiger BioPharmaceuticals, Inc. seller in Q3 2025 was Propel Bio Management, an estimated $423K sold.

Based on aggregated 13F filings for Q3 2025.